Measurement of all aspects of medical care has become the norm these days. We are encouraged to assess the quality of our patients' care in order to improve outcomes and avoid complications of medical treatment. Healthcare providers, both in the public sector and in private medicine, wish to obtain the best value for money. It is therefore necessary to assess the consequences of our clinical decisions in terms of the cost of the treatment and quality of the outcome. This can be done reasonably easily in specialities such as cardiac surgery where operative mortality is an objective method of assessing one surgeon or a hospital team. In venous disease, it is much more complex. Several papers in this issue address the problem of measuring the outcome of treatment for venous disease. Certainly for venous ulceration the time to healing and proportion of healed ulcers can be assessed. However, for patients with varicose veins there are many possible measures which could be used. Should the surgeon or patient simply look at the lower limbs following surgery and express their satisfaction? This is a very subjective method of assessment, especially where the surgeon was the man who did the operation! In some studies where the opinion of the surgeon and the patient have been compared there has been little correlation between the two.
Alternatively more objective means of assessment could be used. Several authors (including myself) have reported duplex ultrasonography and plethysmographic methods of assessing the outcome of surgical treatment for venous disease. These have the advantage of being reasonably objective and there is wide international agreement that these accurately reflect the anatomical and physiological extent of venous disease. Duplex ultrasonography is invaluable in the management of venous disease because of its efficacy in demonstrating the anatomical extent of the problem. To my mind it is an ideal way of evaluating the short and long term outcome of any existing treatment as well as the new treatments for varicose veins. There is one small problem, which was revealed by the Edinburgh Vein Study, aspects of which have been published in the pages of Phlebology. This study demonstrated a poor correlation between the extent of the venous disease demonstrated by duplex ultrasonography and the symptoms which the authors considered might arise from venous disease in a large cohort of the population. This led some to suggest that the eminent authors of this study were betraying the cause of phlebology! However, in reality it simply shows that patients' individual experiences of symptoms arising from venous disease vary considerably. This is probably dependent on a large number of additional factors that confound studies of this type. It seems to be impossible reliably to measure the severity of symptoms in patients suffering from venous disease. Some authors have turned to using validated health questionnaires such as the SF36 which enquires about general health and wellbeing, and the CIVIQ which is specific to venous disease. Some evidence has been published which confirms that these instruments of measurement show modest sustained improvement following surgical treatment of varicose veins. This is clearly far from what duplex ultrasonography would tell us and indicates nothing of the physiological improvement but can be used to indicate the outcome to patients. Such data can then be presented to healthcare providers as evidence of the value of phlebologists to their patients. Papers reporting the results of this type of measurement appear in this issue of Phlebology and confirm that treatment for venous disease results in an improvement in wellbeing. This information is certainly useful and reinforces the value of varicose vein surgery when discussing matters of funding with healthcare providers. However, measures of venous disease will continue to present a problem. 136 I continue to think that duplex ultrasonography is an excellent means of investigating the anatomy of venous problems and perhaps in predicting recurrence from new methods of management of varicose veins. This method has relatively poor correlation with either the physiological improvement in venous function measured plethysmographically or with patient symptoms. Where detailed information about calf pump function is required, for example following operations to reconstruct the deep Philip Coleridge Smith veins, it will be necessary to use plethysmography to evaluate these methods. The CEAP clinical classification was useful for defining the patient group included in a study, but was not intended as an outcome measure for clinical trials, In future, clinicians will have to consider carefully the information they require when asking the question, 'How good is my treatment for venous disease?'. The methodology of the study will have to be carefully selected according to the answer required!
